Canada’s RavenQuest BioMed prioritises innovation and scientific efficacy above sheer scale, could their research answer the questions the cannabis industry is missing?
While it’s true that Canada’s cannabis industry has been leading the way on legislation and acceptance of cannabis as both a medicine and a recreational product, what’s also true is that the industry still has a long way to go to reach the standards necessary for medical acceptance worldwide. This means consistent, repeatable cannabis that physicians can depend upon to deliver the same desired efficacy time and time again for patients or even recreational consumers.
Believe it or not, even in Canada where cannabis production and cleanliness standards are the highest in the world, finding a cannabis product that can be counted on to deliver repeatable levels of THC, CBD and other cannabinoids or terpene profiles is still an elusive goal that is difficult to achieve.
The pathway toward
... read more at: https://www.healtheuropa.eu/ravenquest-biomed-cannabis-industry/90725/